These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


541 related items for PubMed ID: 26584339

  • 21. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Lachin JM, Orchard TJ, Nathan DM, DCCT/EDIC Research Group.
    Diabetes Care; 2014; 37(1):39-43. PubMed ID: 24356596
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM.
    Arch Intern Med; 2011 Mar 14; 171(5):412-20. PubMed ID: 21403038
    [Abstract] [Full Text] [Related]

  • 25. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug 14; 44(8):968-83. PubMed ID: 7622004
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct 14; 45(10):1289-98. PubMed ID: 8826962
    [Abstract] [Full Text] [Related]

  • 29. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.
    White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD, DCCT-EDIC Research Group.
    Diabetes; 2010 May 14; 59(5):1244-53. PubMed ID: 20150283
    [Abstract] [Full Text] [Related]

  • 30. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Van Den Eeden SK, Sarma AV, Rutledge BN, Cleary PA, Kusek JW, Nyberg LM, McVary KT, Wessells H, Diabetes Control and Complications Trial/Epidemiology of Diabetes Research Group.
    Diabetes Care; 2009 Apr 14; 32(4):664-70. PubMed ID: 19171725
    [Abstract] [Full Text] [Related]

  • 31. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
    Nathan DM, DCCT/EDIC Research Group.
    Diabetes Care; 2014 Apr 14; 37(1):9-16. PubMed ID: 24356592
    [Abstract] [Full Text] [Related]

  • 32. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER, Adkins L, Loader CJ, Han H, Rice KM, Denvir J, Driscoll HK.
    Diabetes Res Clin Pract; 2015 Feb 14; 107(2):280-9. PubMed ID: 25467622
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mortality in Type 1 Diabetes in the DCCT/EDIC Versus the General Population.
    Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group.
    Diabetes Care; 2016 Aug 14; 39(8):1378-83. PubMed ID: 27411699
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort.
    Jacobson AM, Braffett BH, Cleary PA, Gubitosi-Klug RA, Larkin ME, DCCT/EDIC Research Group.
    Diabetes Care; 2013 Oct 14; 36(10):3131-8. PubMed ID: 23835693
    [Abstract] [Full Text] [Related]

  • 37. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.
    Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Lachin JM, White NH, Hainsworth DP, Sun W, Cleary PA, Nathan DM.
    Diabetes; 2015 Feb 14; 64(2):631-42. PubMed ID: 25204977
    [Abstract] [Full Text] [Related]

  • 38. Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.
    Genuth SM, Backlund JY, Bayless M, Bluemke DA, Cleary PA, Crandall J, Lachin JM, Lima JA, Miao C, Turkbey EB, DCCT/EDIC Research Group.
    Diabetes; 2013 Oct 14; 62(10):3561-9. PubMed ID: 23520132
    [Abstract] [Full Text] [Related]

  • 39. Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy.
    Hirai FE, Tielsch JM, Klein BE, Klein R.
    Ophthalmology; 2011 Feb 14; 118(2):353-8. PubMed ID: 20884058
    [Abstract] [Full Text] [Related]

  • 40. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    DCCT/EDIC Research Group, Nathan DM, Bebu I, Hainsworth D, Klein R, Tamborlane W, Lorenzi G, Gubitosi-Klug R, Lachin JM.
    N Engl J Med; 2017 Apr 20; 376(16):1507-1516. PubMed ID: 28423305
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.